Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb;18(2):e13239.
doi: 10.1111/irv.13239.

High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors

Affiliations

High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors

Mathurin Cyrille Tejiokem et al. Influenza Other Respir Viruses. 2024 Feb.

Abstract

Background: Healthcare workers (HWs) are at a high risk of exposure to emerging health threats. Following the first wave of the coronavirus disease 2019 pandemic in Cameroon, we explored the presence and persistence of naturally acquired antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the factors associated with seropositivity in HWs.

Methods: Staff at two referral hospitals in Yaoundé or two Health District Hospitals in Obala and Mbalmayo were included in a 6-month prospective cohort analysis or cross-sectional survey, respectively. Seroprevalence and associated factors were determined, and Kaplan-Meier curves and Cox proportional hazards models were used to assess antibody persistence or positive seroconversion over time.

Results: From August 2020 to March 2021, 426 HWs (median age: 31 years, interquartile range: 27-37 years; 66.4% female) were enrolled. The overall seroprevalence of anti-SARS-CoV-2 antibodies was 54.0% (95% confidence interval [CI]: 49.1-58.8) and was significantly different between study sites (p = 0.04). Of the 216 HWs included in the 6-month cohort, 109 (50.5%) HWs were seropositive at inclusion; the probability of persistent antibodies or of becoming seropositive was 93.8% (95% CI: 84.2-100) and 78.9% (95% CI: 61.7-88.4), respectively. Seroconversion was associated with study site and occupation but not with infection prevention and control (IPC) practices.

Conclusions: We observed high seroprevalence of SARS-CoV-2 antibody and seroconversion among HWs associated with occupational risk. This suggests low compliance to the COVID-19 control measures. Continued training and implementation of IPC measures and accelerated preparedness are needed to better tackle future threats.

Keywords: Cameroon; SARS-CoV-2 infection antibody testing; antibody persistence; health personnel; seroepidemiologic studies.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant financial or non‐financial interests to disclose.

Figures

FIGURE 1
FIGURE 1
Kaplan Meier curves presenting (A) the probability of health care workers initially seronegative to become seropositive (B) the probability of health care workers initially seropositive to maintain their serological status over 6 months follow‐up, August 2020 to August 2021, Cameroon. The solid line indicates the probability and the shaded area represents the 95% confidence bands.

Similar articles

References

    1. Haldane V, De Foo C, Abdalla SM, et al. Health systems resilience in managing the COVID‐19 pandemic: lessons from 28 countries. Nat Med. 2021;27:964‐980. - PubMed
    1. Weekly epidemiological update on COVID‐19‐15 February 2022. Accessed 18 April 2023. Available at: https://www.who.int/publications/m/item/weekly-epidemiological-update-on...
    1. Sorbello M, El‐Boghdadly K, Di Giacinto I, et al. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia. 2020;75:724‐732. - PubMed
    1. CDC COVID‐19 Response Team . Characteristics of Health Care Personnel with COVID‐19 ‐ United States, February 12–April 9, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:477‐481. - PMC - PubMed
    1. Remuzzi A, Remuzzi G. COVID‐19 and Italy: what next? Lancet. 2020;395:1225‐1228. - PMC - PubMed

Publication types

Substances